1. Home
  2. KEEL vs NUVB Comparison

KEEL vs NUVB Comparison

Compare KEEL & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Keel Infrastructure Corp. Common Stock

KEEL

Keel Infrastructure Corp. Common Stock

N/A

Current Price

$3.42

Market Cap

2.0B

Sector

Finance

ML Signal

N/A

Logo Nuvation Bio Inc.

NUVB

Nuvation Bio Inc.

N/A

Current Price

$5.57

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEEL
NUVB
Founded
2017
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
KEEL
NUVB
Price
$3.42
$5.57
Analyst Decision
Strong Buy
Buy
Analyst Count
12
10
Target Price
$6.55
★ $13.10
AVG Volume (30 Days)
★ 25.0M
4.0M
Earning Date
11-12-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 71.56
EPS
N/A
★ N/A
Revenue
★ $229,276,000.00
$62,902,000.00
Revenue This Year
N/A
$212.89
Revenue Next Year
N/A
$41.68
P/E Ratio
N/A
★ N/A
Revenue Growth
72.03
★ 698.96
52 Week Low
$2.96
$3.36
52 Week High
$7.37
$9.75

Technical Indicators

Market Signals
Indicator
KEEL
NUVB
Relative Strength Index (RSI) 44.85 36.84
Support Level $3.09 $5.28
Resistance Level $3.91 $5.77
Average True Range (ATR) 0.21 0.24
MACD -0.01 -0.04
Stochastic Oscillator 24.75 14.87

Price Performance

Historical Comparison
KEEL
NUVB

About KEEL Keel Infrastructure Corp. Common Stock

Keel Infrastructure Corp is a North American digital infrastructure and energy company that develops and owns data centers and energy infrastructure for high-performance computing workloads, including AI. The group has a pipeline of 2.2 gigawatts and established grid interconnections already in place. It delivers scalable infrastructure solutions in high-demand power markets across Pennsylvania and Washington in the United States, and Quebec in Canada. It has data campuses in Moses Lake, Panther Creek, Sharon, Sherbrooke, and Scrubgrass.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: